ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,902Medicare Part D Prescriptions Filled, Including Refills

Rank: 340 out of 2343

$768K Total Retail Price of All Prescriptions

Rank: 266 out of 2343

513 Patients Receiving at Least One Drug in Part D
82%Patients 65 Years and Older
62% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Pennsylvania
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 513 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

3% of this provider’s 513 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

1% of this provider’s 10,536 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

30% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$64 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

23 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Pennsylvania
FUROSEMIDE 485 463 1 6
LEVOTHYROXINE SODIUM 479 452 2 2
SIMVASTATIN 453 380 3 1
OMEPRAZOLE 360 293 4 4
LISINOPRIL 359 327 5 3
AMLODIPINE BESYLATE 328 307 6 5
METOPROLOL TARTRATE 284 283 7 7
DONEPEZIL HCL 215 215 8 21
HYDROCHLOROTHIAZIDE 208 203 9 11
CRESTOR 205 168 10 30
WARFARIN SODIUM 196 196 11 8
NAMENDA 164 164 12 36
METFORMIN HCL 164 143 12 9
ATORVASTATIN CALCIUM 159 151 14 10
SPIRIVA 152 114 15 48
PANTOPRAZOLE SODIUM 149 125 16 22
GABAPENTIN 147 137 17 16
ZETIA 132 116 18 52
DIOVAN 129 111 19 23
CLOPIDOGREL 118 110 20 26
ADVAIR DISKUS 116 100 21 34
SERTRALINE HCL 111 108 22 20
ALENDRONATE SODIUM 110 86 23 28
TAMSULOSIN HCL 109 97 24 29
ATENOLOL 107 86 25 12
FLUTICASONE PROPIONATE 101 79 26 46
MIRTAZAPINE 101 101 26 41
METOPROLOL SUCCINATE 95 95 28 14
LOVASTATIN 91 66 29 47
DIGOXIN 90 90 30 35
GLIMEPIRIDE 89 81 31 45
ZOLPIDEM TARTRATE 86 75 32 24
ENALAPRIL MALEATE 81 80 33 58
PRAVASTATIN SODIUM 80 68 34 15
NEXIUM 78 59 35 33
CITALOPRAM HBR 77 75 36 17
ALLOPURINOL 75 62 37 31
ISOSORBIDE MONONITRATE ER 74 74 38 32
FENTANYL 72 68 S2 39 69
PLAVIX 71 68 40 38
KLOR-CON M20 70 60 41 44
EVISTA 70 70 41 128
AZITHROMYCIN 69 61 43 39
TRICOR 69 35 43 96
ESCITALOPRAM OXALATE 67 60 45 55
LEVOFLOXACIN 67 64 45 106
CARVEDILOL 66 66 47 27
LISINOPRIL-HYDROCHLOROTHIAZIDE 65 65 48 42
QUINAPRIL HCL 65 54 48 73
OXYCODONE-ACETAMINOPHEN 64 56 S2 50 49
NASONEX 63 40 51 209
ACTOS 62 47 52 125
TRAMADOL HCL 59 55 53 25
LOSARTAN POTASSIUM 59 52 53 19
DILTIAZEM 24HR ER 56 53 55 76
VYTORIN 54 53 56 185
FINASTERIDE 53 53 57 80
RISPERIDONE 52 33 58 61
RANITIDINE HCL 52 40 58 43
LIDODERM 50 48 60 130
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 9, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.